DTx (Digital Therapeutics)
The Alcimed Healthcare team works in the field of DTx (Digital Therapeutics), or digital therapies, which is of increasing importance in the healthcare sector, by supporting its clients, particularly industrial players, to gain a better understanding of DTx, their definition, their value contribution for the pharmaceutical and medical device industry, or even the business models of tomorrow including DTx in the value proposition.
THE CHALLENGES RELATED TO DTx OR DIGITAL THERAPEUTICS
What are DTx or digital therapies?
DTx are digital medical devices for prevention, treatment, or follow-up purposes in patient care, actively participating in a mechanism of action and based on clinical evidence. It is still a young concept (<10 years) which aims to become a new section of medicine alongside traditional approaches based on chemistry and biology.
What are the challenges related to DTx?
As with any emerging approach, there are many challenges related to digital therapies:
How do we convince internally of the need to integrate DTx into medium-term strategic thinking?
Beyond the construction of business models, Alcimed can also support its customers when searching for or evaluating potential partners before devising a collaboration, for example.
Such questions can be tackled by benchmarks or, once again, a search for partners. From a perspective where the DTx are integrated into the care pathways, understanding how to fit them in and promoting their place represents an important strategic issue for stakeholders in the world of healthcare.
From a perspective where the DTx are integrated into the care pathways, understanding how to fit them in and promoting their place represents an important strategic issue for stakeholders in the world of healthcare.
HOW DO WE SUPPORT IN YOUR IN YOUR DTx OR DIGITAL THERAPY PROJECTS?
We work both on technological or entrepreneurial state of the art and on market considerations such as the creation of business models or the search for partners. These questions are addressed to us both by pharmaceutical or medtech industrial players and by pure DTx players.
To answer these questions, Alcimed combines external investigation (monitoring and benchmarking, interactions with stakeholders in the sector, etc.) and often internal analysis to align key functions for our clients in the field of DTx. The innovation, R&D, marketing/sales departments, etc. can be involved in the reflection to facilitate a 360° vision of the subject.
Alcimed acts as a partner for its clients on these topics, highlighting our recognized expertise in healthcare, new technologies, and digital technology.
The types of projects we carry out for our clients in this field are:
EXAMPLES OF RECENT PROJECTS CARRIED OUT FOR OUR CLIENTS IN THE FIELD OF DTx
Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.
Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 200 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.
Our dream? To build a team of 1,000 explorers, to design tomorrow's world hand in hand with our clients.
- Innovation consulting
- Business case
- Business development
- Business models
- Business plan
- Cluster study
- Collaborative projects
- Commercial strategy
- Competitive analysis
- Customer experience
- Dossier creation
- Due diligence
- Go to market
- Innovation process
- Innovation strategy
- Learning expedition
- Market access
- Market study
- New offers
- New services
- Open innovation
- Opportunity evaluation
- Patient pathway
- Product innovation
- Product launch
- Regulatory framework analysis
- Search for funding opportunities
- Search for partners
- State of the art
- Strategic audit
- Strategic foresight
- Strategic positioning
- Test and Learn
- Value proposition